These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7654449)
21. Antisense therapy in oncology: new hope for an old idea? Tamm I; Dörken B; Hartmann G Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935 [TBL] [Abstract][Full Text] [Related]
22. [The application of antisense technology in ophthalmology]. Guo Y; Ge J Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046 [TBL] [Abstract][Full Text] [Related]
24. Antisense molecules for targeted cancer therapy. Wacheck V; Zangemeister-Wittke U Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913 [TBL] [Abstract][Full Text] [Related]
25. DNA combination therapy to stop tumor growth. Wickstrom E; Smith JB Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270 [No Abstract] [Full Text] [Related]
26. [Development of antisense nucleotides for therapy]. Wang J; Wang L; Wang Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848 [TBL] [Abstract][Full Text] [Related]
27. Antisense tumor therapy (a dream under construction). Kopper L; Kovalszky I In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725 [TBL] [Abstract][Full Text] [Related]
28. Antisense oligonucleotides for central nervous system tumors. Hall WA; Flores EP; Low WC Neurosurgery; 1996 Feb; 38(2):376-83. PubMed ID: 8869067 [TBL] [Abstract][Full Text] [Related]
29. Applications of antisense oligonucleotides in oncology. Pierga JY; Magdelenat H Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172 [TBL] [Abstract][Full Text] [Related]